Updates
February 16, 2024
The Block Firm Receives Preliminary Approval of $46.5 Million Class Action Settlement
Since 2022, The Block Firm has been pursuing a class action against Acella Pharmaceuticals, the manufacturer of NP Thyroid. The class action alleges that Acella…
January 10, 2024
The Block Firm Investigates a Potential Class Action Against MiMedx Group, Inc.
The Block Firm is investigating a potential class action lawsuit against MiMedx Group, Inc., the maker of the AXIOFILL wound treatment. According to a recently…
December 11, 2023
Warning: SugarMD Advanced Glucose Support is subject to a recall due to “hidden drug ingredients” that can be harmful to health
Testing by the Food & Drug Administration found hidden glyburide and metformin, the active ingredients in diabetes medications that are only available with a prescription,…
July 17, 2023
NP Thyroid Class Action Win: Court Denies Acella’s Motion to Strike
The Block Firm secured two important wins in our case, Faulkner et al v. Acella Pharmaceuticals, on behalf of NP Thyroid patients. On Monday, July…
- « Previous
- 1
- 2
OUR PEOPLE
We’re here when you need us.
![Group 170 Group 170](https://blockfirmllc.com/wp-content/uploads/2022/08/Group-170-1.jpg)